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Polychlorinated dibenzo-p-dioxins and dibenzo-
furans (PCDD/PCDFs), known together as
dioxins, and polychlorinated biphenyls (PCBs)
are ubiquitous, persistent organic pollutants
that act as endocrine disruptors in eco- and bio-
systems. Various industries, the combustion of
solid wastes, and forest fires generate these
xenobiotic pollutants. Human milk surveys
have established a high body burden for these
substances in long-industrialized countries,
such as those in Europe (Schecter and Piskac
2001). These contaminants are highly lipo-
philic and are potentially bioampliﬁed through
the food chain. Humans accumulate such
compounds mainly from foods of animal ori-
gin, including ﬁsh (Smith and Gangolli 2002),
meat, dairy products, and processed foods such
as fish oil (Chen et al. 2003; Rideout and
Teschke 2004). PCDD/PCDFs and PCBs
have long half-lives of 7–10 years in humans.
The body burden and related health effects are
particularly concerning in countries with high
population density, such as Taiwan, due
potentially to the increased numbers of facto-
ries, solid waste incinerators (Tango et al.
2004), and the volume of imported foods from
animal sources.
Our previous study established the trans-
fer of PCDD/PCDFs and PCBs from mother
to infant via the placenta (Wang et al. 2004)
in the general population. These endocrine-
disrupting effects upon thyroid function
might signiﬁcantly affect growth and develop-
ment during fast growth stages of the central
nervous system in the human fetus (Koopman-
Esseboom et al. 1994; Pluim et al. 1992).
These effects on fetal growth and develop-
ment, particularly as related to the ectodermal
layer (Guo et al. 2000; Jacobson and Jacobson
1996), are irreversible and can last for several
years of life (Chen et al. 1992; Jacobson and
Jacobson 1996; Patandin et al. 1999). Dental
health might also be affected (Alaluusua et al.
1999; Wang et al. 2003); however, this mech-
anism awaits further investigation. Early
hypo- or hyperthyroidism or thyroid receptor
alterations can cause permanent behavioral,
intellectual, and neurologic dysfunction, par-
ticularly during the second and third months
of gestation (Utiger 1999). Human thyroid
function is similar to that of other vertebrates,
but the thyroid system is well developed and
functioning at birth (Fisher and Brown 2000).
Animal studies have shown that dioxins and
PCBs might affect thyroid hormone secretion,
transport, and/or action (Leatherland 1999).
More recent studies have shown that low-dose
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
might cause rat thyroid morphologic and
functional abnormalities through gestational
and lactational exposure (Nishimura et al.
2003).
Different dioxin and PCB congeners
might have different toxicities. The approach
that uses toxic equivalent factors to summarize
toxicity is subject to debate particularly for
dioxin-like PCBs (Van den Berg et al. 1998),
because the toxicity of dioxin-like PCBs in the
presence of non-dioxin-like PCBs cannot be
summarized simply by additive effects. The
present study provides an opportunity to
examine both single and summarized levels.
There have been inconsistent outcomes
regarding thyroid function alterations result-
ing from dioxins and PCBs in humans with
background exposure in both the Netherlands
(Koopman-Esseboom et al. 1994; Pluim et al.
1993) and Japan (Matsuura et al. 2001;
Nagayama et al. 1998). Such diverse thyroid
hormone ﬁndings might result from using dif-
ferent matrices (Kimbrough and Krouskas
2001) for measuring exposure (i.e., breast
milk or venous blood), various specimen col-
lection time points, and/or studied isomers
(dioxins, indicator PCBs) for different popula-
tions at unique sample sizes. The aim of this
study is to examine the association between
transplacental exposure to various dioxin and
PCB congeners and thyroid hormone status in
118 mother–newborn pairs from the general
Taiwanese population, taking into account
growth hormones and birth outcomes.
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The aim of this study is to examine the association between transplacental exposure to
dioxins/polychlorinated biphenyls (PCBs) and thyroid and growth hormones in newborns. We
recruited 118 pregnant women, between 25 and 34 years of age, at the obstetric clinic. Personal
data collected included reproductive and medical histories and physical factors. Clinicians gath-
ered placental and umbilical cord serum upon delivery and carefully scored the 118 newborns,
making both structural and functional assessments. We analyzed placentas for 17 polychlorinated
dibenzo-p-dioxins and dibenzofurans and 12 dioxin-like PCB congeners with the World Health
Organization–deﬁned toxic equivalent factors, and six indicator PCBs by high-resolution gas chro-
matography and high-resolution mass spectrometry. We analyzed thyroid and growth hormones
from cord serum using radioimmunoassay. Insulin-like growth factor (IGF)-1, IGF-binding glob-
ulin-3, and thyroxine × thyroid-stimulating hormone (T4 × TSH) were significantly associated
with increased placental weight and Quetelet index (in kilograms per square meter; correlation
coefficient r = 0.2–0.3; p < 0.05). Multivariate analyses showed independently and significantly
decreased free T4 (FT4) × TSH with increasing non-ortho PCBs (r = –0.2; p < 0.05). We suggest
that significant FT4 feedback alterations to the hypothalamus result from in utero exposure to
non-ortho PCBs. Considering the vast existence of bioaccumulated dioxins and PCBs and the
resultant body burden in modern society, we suggest routine screening of both thyroid hormone
levels and thyroid function in newborns. Key words: dioxins, infant, placenta, prenatal exposure
delayed effects, thyroid hormones. Environ Health Perspect 113:1645–1650 (2005).
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Subjects. This is part of a prospective study of
dioxins/PCBs for the general population in
central Taiwan. Subject recruitment was
described in a previous study (Wang et al.
2004) with a detailed birth cohort (Chao et al.
2004). In summary, we invited all pregnant
women visiting the local medical center
between December 2000 and November 2001
to participate in this study. We interviewed
430 subjects at the obstetric clinic, collecting
personal data that included reproductive and
medical histories, and physical factors. The
subjects were all between 25 and 34 years of
age with a single pregnancy and without
known complications, cigarette smoking, or
alcohol consumption during the pregnancy.
Clinicians gathered placental and umbilical
cord blood upon neonate delivery. One well-
trained nurse carefully scored all newborns,
including both structural and functional
assessments, which a physician veriﬁed.
The Human Ethical Committee of the
National Health Research Institutes in Taiwan
reviewed and approved the study protocol.
This study followed the ethical standards for-
mulated from the Helsinki Declarations of
1964 and revised in 2000 (World Medical
Association 2000). Each of the participants
provided informed consent after receiving
a detailed explanation of the study and its
potential consequences.
Specimen and data collections. Immediately
after collection on the ward, technicians divided
each placenta into two equally symmetrical
parts, taking half for the study sample.
Technicians then sliced each sample into pieces,
storing 100 g of each sample in Teﬂon-lined
cap glass bottles for future dioxin and PCB
measurements, and then shipped the frozen
placental sections to O. Päpke in ERGO
Research Laboratory (Hamburg, Germany),
which is certified by the World Health
Organization (WHO), for analysis. This labo-
ratory regularly and successfully participates in
international interlaboratory studies, including
PCDD/PCDFs in human milk, beef, and ﬁsh
liver (Päpke 1998).
Analyses of PCDD/PCDFs and PCBs
were performed according to a previously pub-
lished method (Päpke et al. 1994). Brieﬂy, we
extracted 100-g placenta samples with n-pen-
tane after adding an internal standard, such as
13C12-PCDD/PCDF or 13C12-PCB. We
determined the lipid content of the samples
using a gravimetric method before cleanup in
a multicolumn system. The congeners, with
the WHO-defined toxic equivalent factors
(Van den Berg et al. 1998) of seventeen
2,3,7,8-substituted  PCDD/PCDFs, 12
dioxin-like PCBs including non-ortho and
mono-ortho PCBs, and six indicator PCBs
[International Union for Pure and Applied
Chemistry (IUPAC) congeners 28, 52, 101,
138, 153, and 180] were analyzed by gas chro-
matography (Hewlett Packard GC 5890
Series II; GMI Inc., Ramsey, MN, USA) with
high-resolution mass spectrometry (VG-
AutoSpec, Manchester, UK). We purchased
authentic standards of native dioxin-like PCBs
and PCDD/PCDFs from AkkuStandard Inc.
(New Haven, CT, USA). We obtained indica-
tor PCB standards from LGC Promochem
(Wesel, Germany). We then measured two iso-
tope masses for each component. We used
internal/external standard mixtures via the iso-
tope dilution method for quantiﬁcation.
In our study we examined 118 newborns
with complete data including dioxin/PCB levels
in the placenta and thyroid hormone status via
the cord serum. We noted increased thyroid
hormone levels during the ﬁrst few hours of life
due to the expected postparturition surge of
thyroid-stimulating hormone (TSH). Thyroid
hormone concentration measurements in the
cord blood were similar to those measured in
the venous blood at 24–72 hr or 2 weeks of age
(Mashang and Thornton 1999). We collected
cord blood upon umbilical cord ligation, which
we completed within 1 min of childbirth; thus,
we used cord levels as indices of thyroid func-
tion without phlebotomizing the infants. The
decreased number of subjects reported is a
result of the economic dioxin analyses necessary
to achieve a statistical power sufﬁcient to gener-
ate a valid conclusion. Thyroid and related
growth hormones were measured using radio-
immunoassay methods, including triiodothyro-
nine (T3), thyroxine (T4), thyroid-stimulating
hormone (TSH; thyrotropin), free T4 (FT4),
T3 uptake, thyroid-binding globulin (TBG),
insulin-like growth factor (IGF)-1, and IGF-
binding globulin-3 (BP3). We carried out blind
duplicates for every 10 samples. We purchased
T3, T4, TSH, IGF-1, and BP3 commercialized
kits from Daiichi Radioisotope Laboratory
(Tokyo, Japan). FT4 kits were from CIS Bio
International US Inc. (Bedford, MA, USA);
T3 uptake kits were from Diagnostic Products
Corporation (Los Angeles, CA, USA); TBG kits
were from CIS BIO International (Marcoule,
France).
Statistical methods. We verified the data
distribution of each continuous variable for
normality and generally noted data skewing
Wang et al.
1646 VOLUME 113 | NUMBER 11 | November 2005 • Environmental Health Perspectives
Figure 1. Concentrations of T3 (ng/dL), T4 (µg/dL),
TSH (µU/mL), and FT4 × TSH (ng/dL × µU/mL) in
cord serum according to quartiles of total dioxins
and PCBs (pg-TEq/g lipid) in placenta: (A) females;
(B) males.
*p < 0.05; #p < 0.1.
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Figure 2. Concentrations of T3 (ng/dL), T4 (µg/dL),
TSH (µU/mL), and FT4 × TSH (ng/dL × µU/mL) in
cord serum according to quartiles of non-ortho
PCBs (pg-TEq/g lipid) in placenta: (A) females;
(B) males.
*p < 0.05; #p < 0.1.
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Bslightly to the right. When data distribution
was signiﬁcantly beyond the normal distribu-
tion range, we used the Mann-Whitney U-test
for determining differences (i.e., hormone lev-
els) between high- and low-exposure groups;
otherwise, we performed the Student t-test.
We used the chi-square test for categorical
variables. We calculated the multiplied con-
centrations of FT4 × TSH based on the nor-
mal hypothalamic–pituitary axis in which
decreased T4 feeds back to the hypothalamus
and thereby stimulates the anterior pituitary to
secret TSH (Scanlon and Hall 1998). We also
calculated the concentration ratio of T4:TBG
because TBG is the main T4 carrier protein,
and generally there is positive association
between the concentrations of T4 and TBG
(Porterﬁeld 2001). We used Spearman corre-
lation analyses to evaluate the association
between PCDD/PCDF and PCB levels and
hormone levels. For the present report, we
confirmed the results using Pearson correla-
tion analyses after log transformation. We
used a general linear model to examine the
relationship of the hormone log values to the
dioxin/PCB exposure values. To increase sta-
tistical power, we combined the results of male
and female infants when their patterns were
the same. We carried out multivariate linear
regression analyses to adjust for age and other
appropriate variables. We used the Statistical
Package for Social Science (version 10.0;
SPSS, Chicago, IL, USA) to execute all statis-
tical analyses. For data presentation, we used
international units (IU), except for Figures 1
and 2 in which IU was not used to illustrate
different hormone levels in single ﬁgures.
Results
The newborns were generally healthy with a
mean (± SD) body weight of 3,229 ± 371 and
Apgar scores at 1 and 5 min of 8.4 and 9.7,
respectively. The mothers had a mean (± SD)
age of 29 ± 4 years (Table 1). Male infants
tended to have greater birth weights and head
girths (p < 0.1) than did female infants.
Approximately half of the infants were first
parity, with an even distribution of males and
females. Higher dioxin/PCB exposure groups
correlated signiﬁcantly with increased mater-
nal age and longer infant length. Higher par-
ity might confound the length relationship,
although this relationship did not persist with
multivariate analysis. One- and 5-min Apgar
scores were both slightly lower in the high-
exposure group, but this was without statisti-
cal signiﬁcance (p = 0.19, 0.35, respectively).
Table 2 demonstrates significantly increased
concentrations of T3, TBG, and BP3 and
decreased TSH in female infants, whereas in
males, decreased TSH values were not statisti-
cally significant. The 95% confidence inter-
vals (CIs) for T3, T4, TSH, and FT4 were
54.3–60.6 (ng/dL), 8.4–9.1 (µg/dL), 6.8–8.9
(µU/mL), and 0.77–0.85 (ng/dL), respec-
tively. The concentrations in the present
study were within the normal range for cord
blood (Mashang and Thornton 1999). We
excluded one subject who was seen in follow-
up for thyroid dysfunction and dropped out
of the study from the present report.
Maternal age was significantly associated
with decreased gestational age and Apgar
scores (Table 3). Further analyses showed that
maternal age correlated with increased parity
and was associated with increased infant
weight and length. Therefore, the greater the
parity, the shorter the gestational age for an
infant with a normal-range weight. IGF-1 and
BP3 concentrations in cord serum were signif-
icantly and positively associated with greater
placental weight, birth weight, head girth, and
Quetelet index (QI) (correlation coefficient,
0.2–0.3). FT4 × TSH and T4 × TSH were
both significantly and positively associated
with placental weight and QI (r = 0.2–0.3).
Maternal thyroid hormones at the third
trimester of pregnancy did not correlate with
birth outcomes; therefore, these are not
included in the present report.
Dioxins and thyroid function in newborns
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Table 1. Birth outcomes by sex and median of dioxin and PCB TEq level in the newborn babies (mean ± SD).
Sex (n) Dioxin/PCB TEqa (pg/g lipid)
Factor (unit) Female (n = 62) Male (n = 57) p-Valueb Low (< 15.1; n = 59) High (≥ 15.1; n = 60) p-Valueb Total factor (unit)
Dioxin/PCB TEq 16.38 ± 6.76 16.01 ± 5.44 0.75 11.59 ± 2.43 20.74 ± 5.24 < 0.001 16.20 (6.14)
Mother’s age 29.81 ± 4.60 28.65 ± 4.11 0.15 27.54 ± 4.03 30.93 ± 4.10 < 0.001 29.35 (4.04)
Placenta weight (g) 574.4 ± 150.4 571.7 ± 138.6 0.92 582.5 ± 165.5 563.7 ± 119.7 0.50 568.2 (122.5)
Placenta fat content (%) 0.75 ± 0.10 0.75 ± 0.13 0.98 0.75 ± 0.11 0.75 ± 0.11 0.94 0.77 (0.12)
Gestational age (weeks) 38.64 ± 1.33 39.15 ± 1.42 0.05 39.00 ± 1.31 38.76 ± 1.47 0.35 38.80 (1.37)
Baby birth weight (g) 3,051 ± 411.7 3,181 ± 416.3 0.09 3,062 ± 416.6 3,163 ± 415.3 0.19 3,229 (371.1)
Baby birth length (cm) 51.09 ± 2.27 51.66 ± 2.46 0.19 50.90 ± 2.34 51.82 ± 2.33 0.03 51.86 (2.21)
QI (kg/m2) 11.66 ± 1.27 11.90 ± 1.18 0.29 11.78 ± 1.22 11.77 ± 1.25 0.95 12.01 (1.20)
Baby head girth (cm) 33.23 ± 1.37 33.69 ± 1.21 0.05 33.39 ± 1.38 33.51 ± 1.25 0.62 33.69 (1.25)
Baby chest girth (cm) 32.75 ± 1.70 32.94 ± 1.73 0.55 32.82 ± 1.65 32.86 ± 1.79 0.91 33.07 (1.64)
1st min Apgar score 8.59 ± 1.28 8.32 ± 0.76 0.16 8.55 ± 1.34 8.37 ± 0.71 0.35 8.35 (0.75)
5th min Apgar score 9.92 ± 1.13 9.68 ± 0.47 0.15 9.91 ± 1.16 9.70 ± 0.46 0.19 9.73 (0.45)
Baby bilirubin (mg/dL) 8.80 ± 2.61 7.93 ± 2.31 0.07 8.62 ± 2.64 8.09 ± 2.33 0.27 7.96 (2.30)
Parity (%)
1st 53 54 0.95c 58 50 0.63c 54 (64)
2nd 32 30 27 35 31 (37)
≥ 3rd 15 16 15 15 15 (18)
aThe 17 PCDD/F and 12 dioxin-like PCB congeners with the WHO toxic equivalent factors were measured in the placenta. bMann-Whitney U-test adjusted for mother’s age for all the
characteristics examined. cChi-square test p-value.
Table 2. Hormone concentrations by median of dioxins/PCB TEq (pg/g lipid, mean ± SD) level in the female and male babies.
Female Male
Hormone Low (< 15.1; n = 31) High (≥ 15.1; n = 31) p-Valuea Total Low (< 15.2; n = 28) High (≥ 15.2; n = 29) p-Valuea Total
T3 (nmol/L) 0.79 ± 0.18 0.91 ± 0.28 0.05# 0.85 ± 0.24 0.96 ± 0.32 0.88 ± 0.24 0.34 0.92 ± 0.28
T4 (nmol/L) 105.8 ± 22.7 115.7 ± 19.6 0.07# 110.8 ± 21.7 112.9 ± 28.8 116.5 ± 21.3 0.59 114.8 ± 25.0
T3 uptake (%) 30.5 ± 4.36 28.9 ± 4.08 0.15 29.7 ± 4.26 28.1 ± 5.22 28.0 ± 3.44 0.94 28.1 ± 4.37
FT4 (pmol/L) 10.7 ± 3.2 10.8 ± 2.3 0.85 10.7 ± 2.8 10.4 ± 2.4 9.93 ± 2.7 0.44 10.2 ± 2.6
TSH (mU/L) 9.23 ± 5.7 6.86 ± 5.3 0.10# 8.03 ± 5.6 8.46 ± 6.5 6.99 ± 5.5 0.38 7.67 ± 6.0
TBG (mg/L) 21.9 ± 3.95 24.6 ± 4.82 0.03* 23.2 ± 4.57 25.0 ± 7.21 25.1 ± 4.47 0.94 25.0 ± 5.86
IGF-1 (ng/dL) 85.2 ± 38.6 99.1 ± 36.0 0.15 95.2 ± 37.7 82.3 ± 35.3 86.0 ± 36.6 0.70 84.3 ± 34.7
BP3 (ng/dL) 1.23 ± 0.44 1.64 ± 0.84 0.02* 1.43 ± 0.70 1.54 ± 0.86 1.38 ± 0.87 0.51 1.46 ± 0.86
aStudent t-test or Mann-Whitney U-test when data distribution was signiﬁcantly beyond the normal distribution range: *p < 0.05, #p < 0.1.We examined whether the key growth- and
development-related hormones in cord blood
were associated with dioxin/PCB body burden
after adjusting for maternal age (Table 4). We
found significant correlations mainly for
female infants. First, increased T3 levels were
associated with increased PCDFs. Second,
decreased TSH levels were associated with
increased PCDDs and dioxin-like PCBs.
Third, increased TBG levels were associated
with increased PCDD/PCDFs. Fourth,
decreased FT4 × TSH levels were associated
with increased non-ortho PCBs. Fifth,
decreased T4:TBG and T3 uptake:T3 levels
were associated with increased PCDD/PCDFs.
The concentrations of PCB-138, -153, and -
180 were not signiﬁcantly associated with key
hormone levels and related only somewhat to
T4 and FT4 levels in females.
Table 5 shows the results of multivariate
analyses for signiﬁcant relationships between
the hormone and dioxin/PCB levels after
adjusting for maternal age and other dioxin/
PCB isomers. We combined PCDDs and
PCDFs with the same relationship pattern to
increase statistical power. We noted the con-
tinuation of a signiﬁcant and positive associa-
tion between T4 concentrations with levels of
PCDD/PCDFs. We also noted a significant
relationship between TBG levels and increased
PCDF levels. FT4 × TSH levels were nega-
tively associated with non-ortho PCB toxic
equivalents (TEq; r = –0.25) and positively
related to concentrations of PCB-138, -153,
and -180 (r = 0.02; data not shown) indepen-
dent of age and other congeners. We noted a
negative relationship between FT4 levels and
non-ortho PCB levels. In addition, maternal
age was negatively associated with T4, TBG,
and FT4 × TSH. Mainly because of low levels
and values below the detection limit, mono-
ortho PCBs have not demonstrated a signifi-
cant association with hormone levels.
We also noted increased T3 and T4 con-
centrations, as well as decreased TSH and
FT4 × TSH, with increasing total dioxins and
PCB TEq levels, the latter two statistically sig-
nificant for female infants (Figure 1A). For
male infants, similar patterns were not statisti-
cally signiﬁcant (Figure 1B). Non-ortho PCBs
were associated with decreased FT4 × TSH for
both sexes after examining various congener
groups (Figure 2). Each subject’s level was
plotted for non-ortho PCBs against FT4 × TSH
(Figure 3). Both linear and nonlinear models
demonstrated a signiﬁcant negative association.
The 95% CIs for values of FT4 × TSH and
T4 × TSH were 5.5–7.4 ng/dL × µU/mL and
58.3–78.5 µg/dL × µU/mL, respectively.
Discussion
This is the first study demonstrating the
in utero effects, as measured in the placenta, of
dioxins and PCBs on thyroid function, consid-
ering various growth factors in newborn infants
from the general population. Thyroid function
is crucial for infant growth and development
(Polk and Fisher 1998), and previous studies of
38 healthy, term infants have shown borderline
signiﬁcance for increased T4 and TBG concen-
trations in upper-median dioxin-exposed
groups as measured in breast milk (Pluim et al.
1992, 1993). Here, we demonstrate consis-
tently increased T3, T4, and TBG levels in cord
blood correlating to upper-median exposure
groups for female but not male infants. The
increases in T4 and TBG levels seen with
increasing dioxins persisted even after adjusting
for maternal age and PCB exposure.
We further demonstrated decreased FT4 ×
TSH levels with increasing non-ortho PCBs,
which remained signiﬁcant even after adjust-
ing for other dioxin and PCB congeners. This
phenomenon was most noteworthy in female
infants. FT4 × TSH levels could be predicted
with significance by using a simple linear
regression model with non-ortho PCB TEq
levels as predictors. FT4 is the major hormone
affecting hypothalamus-stimulating TSH
(Scanlon and Hall 1998). FT4 feedback might
not be effective enough to stimulate the hypo-
thalamus to secrete TSH, resulting in decreas-
ing TSH levels. We also demonstrated that
TSH and FT4 × TSH are significantly and
positively associated with placental weight and
QI, signifying the general growth impact from
the two hormones. We recommend routine
thyroid function screening in newborns as a
protective measure in the face of ubiquitous
environmental endocrine disruptors, particu-
larly for bioaccumulated and transplacental
dioxins and the PCB body burden. Such
screening should include both individual thy-
roid hormone levels (i.e., TSH and/or T4) and
relationship values (i.e., FT4 × TSH) for func-
tional evaluations. We did not emphasize the
signiﬁcant reduction of T3 and T4 concentra-
tions with increasing non-ortho PCBs because
of the positive association between the hor-
mone levels and dioxins, particularly for T4 and
PCDDs, possibly due to the increased TBG
concentration with increasing PCDDs. Various
conger considerations are important because of
the multiple exposures that humans receive.
Regarding sex differences, we noted signiﬁ-
cant increases in BP3 in high-exposure female
infants in the present study. Female infants
exposed to slightly higher dioxin and PCB lev-
els were without statistical signiﬁcance, how-
ever, and these female infants generally had
similar hormone levels to the male infants. In
addition, female infants were slightly smaller
and had higher bilirubin levels than did male
infants. It was easier to differentiate hormone
levels by upper- and lower-median dioxin/PCB
levels in females, which indicated greater sensi-
tively to endocrine disruptors in female com-
pared with male neonates. Sex differences in
thyroid hormones were also found in Michigan
Lake fish eaters (Persky et al. 2001). Most
experts consider dioxins antiestrogenic with
context-dependent effects, which might explain
the greater hormonal outcomes observed in
females. Estrogen receptors in thyroid cells
(Scanlon and Hall 1998) and greater responses
Wang et al.
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Table 3. Correlationa between thyroid hormone concentrations in cord serum and birth-related indices.
Maternal Gestational Placenta Birth Birth Baby head 1st min 5th min Baby bilirubin
Hormones age (years) age (weeks) weight (g) weight (g) length (cm) girth (cm) QI (kg/m2) Apgar score Apgar score (mg/dL)
Maternal age 1 –0.271** –0.004 –0.018 0.040 0.023 –0.103 –0.191* –0.025* –0.054
Gestational age –0.271** 1 0.099 0.308*** 0.136 0.169# 0.355*** 0.210* 0.208* –0.015
T3 (nmol/L) –0.069 0.218 –0.157 0.046 –0.006 0.044 0.105 –0.036 –0.042 0.004
T4 (nmol/L) –0.105 0.137 0.020 –0.029 –0.120 –0.075 0.129 0.086 0.044 –0.070
TSH (µU/L) –0.216 0.148 0.288** 0.155# –0.039 0.055 0.205* 0.054 0.066 0.018
T3 uptake (%) 0.025 –0.244** 0.178# 0.022 0.074 0.106 –0.084 –0.049 –0.032 –0.030
FT4 (pmol/L) –0.042 –0.005 0.080 0.009 –0.140 –0.055 0.171# 0.042 0.115 –0.085
TBG (mg/L) –0.063 0.213* 0.051 0.009 –0.107 0.001 0.154 0.120 0.085 –0.062
IGF-1 (nmol/L) 0.069 –0.164# 0.279** 0.309*** 0.112 0.321*** 0.267** –0.139 –0.062 –0.169#
BP3 (nmol/L) –0.086 0.023 0.237* 0.218* 0.050 0.300** 0.234* –0.078 –0.015 –0.119
FT4 × TSH –0.224* 0.148 0.237* 0.117 –0.095 0.016 0.226* 0.081 0.154 –0.039
T4 × TSH –0.255** 0.168# 0.281** 0.118 –0.089 0.002 0.229** 0.085 0.097 0.006
T4:TBG –0.031 –0.007 0.004 –0.064 –0.088 –0.125 –0.009 0.008 –0.044 0.015
T3 uptake:T3 0.059 –0.248** 0.177# –0.011 0.066 0.027 –0.116 0.011 0.040 –0.008
FT4:T3 0.023 –0.213* 0.174# –0.054 –0.091 –0.044 0.001 –0.012 0.031 –0.079
aSpearman correlation: ***p < 0.001, **p < 0.01, *p < 0.05, #p < 0.1.of TSH to thyrotropin-releasing hormones in
females might also contribute. Further investi-
gation is necessary to elucidate the reasons
behind these sex differences.
Prior research had different results than
those of the present study. In a study of resi-
dents living in a highly industrialized region
of the Netherlands (Koopman-Esseboom
et al. 1994), dioxins and PCBs in breast milk
collected at 14 days postpartum showed no
association with T4, T3, FT4, and TSH con-
centrations in cord blood but showed signiﬁ-
cantly decreased T4 and increased TSH levels
at 2 weeks and 3 months postpartum. Among
these 78 mother–infant pairs collected from
surrounding industrial areas of Rotterdam,
TSH varied from 10.0 µIU/mL at birth to
2.3 µIU/mL at 2 weeks. Dioxins and PCBs in
breast milk ranked high in Europe at 30.8 pg
TEq/g fat compared with 15.1 in the present
study; however, the method detection limit
has been largely lowered because of technical
improvements in the last 10 years. In addi-
tion, dioxin and PCB levels in breast milk
might decrease with parity and duration of
the feeding; therefore, it is difficult to make
direct comparisons between the Dutch study
and the present study. Nonetheless, both
studies drew the same conclusions regarding
altered thyroid hormone status as related to
dioxins and PCB exposure, and both con-
clude that the data warrant further follow-up.
More recent studies of the general popula-
tion in Japan showed no association between
TSH and FT4 concentrations at 1 year with
dioxins and PCBs in breast milk collected at
30 postpartum days (Matsuura et al. 2001).
This indicated that breast-feeding might not
change thyroid hormone levels significantly.
As recommended by Rogan and Miller (1989),
the ectodermal effects of in utero longer term
dioxin and PCB exposure needs to be examined.
Our study of dioxins and PCBs in 118 placentas
demonstrated associated hormonal changes,
while accounting for various growth factors and
covariates. For instance, we noted higher dioxin
and PCB body loads with increased maternal
age, which results in increased transplacental
and lactational exposure to fetus and infant,
respectively. We suggest that researchers con-
sider age when evaluating the effects of per-
sistent thyroid hormone disruptors. In the
present study, we found that maternal age
was associated with increased dioxin levels,
decreased gestational age, and decreased T4
and TSH concentrations, within 25–34 years
of age. Maternal age adjustments in our study
might explain why our outcomes differed from
those of previous studies.
Animal studies have indicated that thy-
roid function changes according to gestational
and lactational exposure to TCDD and PCBs
(Fisher and Brown 2000; Nishimura et al.
2003; Rosiak et al. 1997). In the offspring of
Holtzman rats sensitive to TCDD, serum T4
levels decreased on postnatal day 21 and
increased by postnatal day 49 when exposed
to a low-dose (either 200 or 800 ng/kg) at
gestational day 15 (Nishimura et al. 2003).
T3 increased at both postnatal day 21 and
postnatal day 49, but this increase was less
significant. Nishimura et al. (2003) con-
cluded the induction of the uridine diphos-
phate-glucuronosyltransferase-1 gene in the
liver increases T4 metabolism. In this animal
study, hyperplasia of the thyroid gland might
result from decreased T4 and sustained high
TSH levels with a corresponding feedback
system disorder. We observed greater T3 lev-
els but did not observe increased TSH levels
in female neonates in relation to increased
PCDFs. Background exposure might affect
humans differently than animal models. In
addition, levels of TBG, the major T4 carrier
protein in the peripheral blood (LaFranchi
2000), were significantly increased with
dioxin exposure. TBG might be increased
during pregnancy secondary to maternal
estrogen effects (Mashang and Thornton
1999); therefore, researchers recommended
further analyses of estrogens in cord blood.
We found FT4 and T3 uptake were slightly
and negatively associated with dioxins, indi-
cating there might be fewer unoccupied bind-
ing sites on TBG. Additional studies to
examine carrier protein changes using animal
models would help further clarify regulation
processes and help deﬁne the reference levels
for pathologic diagnosis.
Although indicator PCBs have been asso-
ciated with decreased T4 levels and sustained
TSH stimulation in Sprague-Dawley pups
(Ness et al. 1993), the present study found no
major correlation between the various thyroid
hormones and PCB-138, -153, and -180.
The only correlation noted in this study was
Dioxins and thyroid function in newborns
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Table 4. Correlationa between PCDD/Fs and PCB levels in toxic equivalence and thyroid hormone concen-
trations in cord serum by infant’s sex.
Infant Mother’s Non-ortho Mono-ortho PCB-138,
Hormone sex age PCDDs PCDFs PCBs PCBs -153, -180
T3 (nmol/L) F 0.097 0.214 0.300* 0.216 0.227# 0.074
M –0.220 –0.090 –0.039 –0.008 0.070 0.035
T4 (nmol/L) F 0.066 0.191 0.253# 0.189 0.191 0.282#
M –0.236# 0.116 0.231# –0.137 0.172 0.183
TSH (µU/L) F –0.223# –0.265* –0.233# –0.320* –0.264* –0.154
M –0.225 –0.214 0.015 –0.130 –0.239# –0.078
T3 uptake (%) F –0.059 –0.177 –0.172 0.074 0.024 0.019
M 0.057 0.007 –0.048 –0.003 –0.237# –0.179
FT4 (pmol/L) F 0.062 –0.004 –0.017 0.058 0.022 0.247#
M –0.172 –0.182 0.058 –0.302* –0.178 –0.033
TBG (mg/L) F 0.121 0.319* 0.368** 0.118 0.189 0.136
M –0.176 –0.039 0.118 –0.141 0.107 0.054
IGF-1 (nmol/L) F 0.175 0.073 0.053 –0.035 –0.110 –0.196
M –0.084 –0.045 –0.006 –0.179 –0.061 –0.018
BP3 (nmol/L) F 0.161 0.185 0.254# –0.097 –0.061 –0.215
M –0.329* –0.190 –0.141 –0.204 –0.253 –0.208
FT4 × TSH F –0.239# –0.218 –0.187 –0.294* –0.243# –0.210
M –0.249 –0.210 0.047 –0.291 –0.276 –0.035
T4:TBG F –0.067 –0.305* –0.270# 0.046 –0.068 0.082
M –0.002 0.082 0.049 0.057 –0.002 0.110
T3 uptake:T3 F –0.073 –0.224# –0.282* –0.144 –0.152 < 0.001
M 0.146 0.021 –0.023 0.014 –0.156 –0.151
FT4:T3 F –0.063 –0.188 –0.242# –0.134 –0.162 0.131
M 0.088 –0.059 0.023 –0.188 –0.176 –0.040
aSpearman correlation: **p < 0.01, *p < 0.05, #p < 0.1.
Table 5. Correlation coefﬁcientsa between PCDD/F
and PCB levels and thyroid hormone concentra-
tions in cord serum by stepwise multivariate linear
regression.
Mother’s Non-ortho
Hormone age PCDD/Fs PCBs
T4 –0.274** 0.202# —
TBG –0.201# 0.286* —
FT4 — — –0.277**
FT4 × TSH –0.218* — –0.246*
aThe hormones levels were log-transformed for normality
to use the parametric method. **p < 0.01, *p < 0.05, #p < 0.1.
Figure 3. Decreased FT4 × TSH levels according to
concentrations of non-ortho PCBs. By general lin-
ear model: FT4 × TSH = 8.32–1.05 × (non-ortho
PCB); R = 0.245, p = 0.009. By quadratic model: FT4
× TSH = 9.06–1.77 × (non-ortho PCB) + 0.116 × (non-
ortho PCB)2; R = 0.261, p = 0.022.
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Non-ortho PCB TEq (pg/g lipid)that of increased T4 levels with increasing
concentrations of non-dioxin-like PCBs in
female infants as determined by univariate
analysis. Differences in exposure levels of
endocrine disruptors might reveal different
effects (Brouwer et al. 1999).
There are several methodologic concerns in
studies of this nature. First, it is difficult to
draw venous blood from infants who are
< 3 months of age. Nonetheless, the pattern of
hormonal changes remained consistent at 1
and 11 postnatal weeks according to observa-
tion of infants in the general population of the
Netherlands (Pluim et al. 1993). Second, we
did not include routine TSH regulatory moni-
toring results in the present report because
venous concentrations varied with time points
of the blood draws; thus, this was not suitable
data for comparison. The pregnant women in
our study did not have iodine insufficiency
concerns to our understanding, probably
because of the proximity to the sea and dietary
habits, which include the intake of processed
foods using seaweed containing iodine. For
exposure measurements, human milk dioxin/
PCB levels decreased substantially with the
duration of breast-feeding. The percentage of
all congener-specific analyses for PCDD/
PCDF and PCB levels greater than the detec-
tion limit is 90% for placenta, compared with
75% for human milk and 43% for cord serum.
Placental analyses might prove to be good indi-
cators of in utero exposure for newborns.
Conclusions
We found signiﬁcantly decreased FT4 feedback
to the hypothalamus resulting from in utero
exposure to non-ortho PCBs in neonates from
the general population. The mechanism of
action of the compound treatment remains to
be determined. We also recommend routine
screening of both individual thyroid hormonal
levels and thyroid function in newborns, con-
sidering the pervasive existence of bioaccumu-
lated dioxins and PCBs and the resulting body
burden in modern society. We recommend
further studies that include antiestrogenic
effects to examine the positive correlation
between TBG and increased dioxins. It is
worthwhile to follow the growth and develop-
ment for those with altered thyroid status.
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